These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 30277113)

  • 21. Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis.
    Dirican M; Sarandol E; Serdar Z; Ocak N; Dilek K
    Clin Nephrol; 2007 Sep; 68(3):144-50. PubMed ID: 17915616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.
    Danielski M; Ikizler TA; McMonagle E; Kane JC; Pupim L; Morrow J; Himmelfarb J
    Am J Kidney Dis; 2003 Aug; 42(2):286-94. PubMed ID: 12900810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
    Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
    Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress and cardiovascular disease in dialyzed patients.
    Usberti M; Gerardi GM; Gazzotti RM; Benedini S; Archetti S; Sugherini L; Valentini M; Tira P; Bufano G; Albertini A; Di Lorenzo D
    Nephron; 2002 May; 91(1):25-33. PubMed ID: 12021516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients.
    Çolak H; Kilicarslan B; Tekce H; Tanrisev M; Tugmen C; Aktas G; Kursat S
    Ther Apher Dial; 2015 Feb; 19(1):56-62. PubMed ID: 25628169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
    Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K
    Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.
    Yong K; Dogra G; Boudville N; Lim W
    Perit Dial Int; 2018; 38(1):18-23. PubMed ID: 29097485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients.
    Boaz M; Matas Z; Biro A; Katzir Z; Green M; Fainaru M; Smetana S
    Am J Kidney Dis; 1999 Sep; 34(3):438-44. PubMed ID: 10469853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.
    Fassett RG; Driver R; Healy H; Ranganathan D; Ratanjee S; Robertson IK; Geraghty DP; Sharman JE; Coombes JS
    BMC Nephrol; 2009 Mar; 10():8. PubMed ID: 19284599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
    El-Mesallamy HO; Abdel Hamid SG; Gad MZ
    Kidney Blood Press Res; 2008; 31(3):189-95. PubMed ID: 18511874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships between plasma pentraxin 3 levels and inflammation markers patients with tunneled permanent catheter in hemodialysis.
    Yigit IP; Dogukan A; Taskapan H; Comert M; Ilhan N; Ulu R; Aygen B
    J Vasc Access; 2015; 16(5):377-81. PubMed ID: 26070095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammation markers, chronic kidney disease, and renal replacement therapy.
    Lavín-Gómez BA; Palomar-Fontanet R; Gago-Fraile M; Quintanar-Lartundo JA; Gómez-Palomo E; González-Lamuño D; García-Unzueta MT; Arias-Rodríguez MA; Gómez-Gerique JA
    Adv Perit Dial; 2011; 27():33-7. PubMed ID: 22073825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
    Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
    Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in circulating biomarkers during a single hemodialysis session.
    Yamamoto T; Nascimento MM; Hayashi SY; Qureshi AR; Waniewski J; Brodin LÅ; Anderstam B; Lind B; Riella MC; Seeberger A; Lindholm B
    Hemodial Int; 2013 Jan; 17(1):59-66. PubMed ID: 22716238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients.
    Valentini J; Grotto D; Paniz C; Roehrs M; Burg G; Garcia SC
    Biomed Pharmacother; 2008; 62(6):378-82. PubMed ID: 18166291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.